Bess Pharmaceutical's super antibody was launched in great anticipation, but Bess Pharma did not bring surprises to the American people, on the contrary, it was a great shock. Whether the effect of super antibodies is super good or not, I can't see it yet. But the price is really super outrageous. Compared with Fahrenheit's most expensive anti-cancer drug, it is several times more expensive. The excuse of Bess Pharmaceutical is that this super antibody can comprehensively improve the patient's resistance and completely remove various lesions in the patient's body. It can even have a good effect on myopic eyes. In other words, although the price is cheap, one medicine is worth the money when it is used for 100 medicines. The question is, who has nothing to do after eating, and is sick and playing every day?

The price of a super antibody is $50,000. The price is absolutely sky-high, but if it's just because of a cold, do you still have to spend $100,000 to buy the super antibody of Bess Pharmaceutical?

In this regard, Steve said: "Even if you have a cold, it seems a bit too much luxury to use super antibodies. However, with the use of super antibodies, the patient becomes disease-free. It can be immune to the invasion of any virus, and at the same time, the physique will be qualitatively improved. It is equivalent to once and for all, and you will never have to worry about illness in the future. The ultimate in the true sense of the word. ”

But this price is simply unaffordable even for ordinary people in developed countries. Although Fahrenheit's drugs are expensive, they are very carefully classified. Drugs for major illnesses are expensive, and drugs for minor illnesses are cheap. This makes it easier to be accepted by the population. Now Bess Medicine is indeed a medicine for all diseases. Who would want to take an expensive drug when they are healthy? And the purpose is just to cure your own cold?

After the product release of BS Pharmaceutical. The U.S. Bureau of Commerce has eagerly opened an antitrust investigation into Fahrenheit. The U.S. Bureau of Commerce's move provoked a strong reaction from the Fahrenheit Group.

"Fahrenheit is committed to providing the best possible treatment for patients around the world. Let their diseases receive the safest, most timely and most effective treatment. Our efforts have also been recognized by patients around the world. It is an irrefutable fact that patients almost all over the world choose to use Fahrenheit's pharmaceutical products. However, the U.S. Bureau of Commerce ignored this actual situation and launched an antitrust investigation against Fahrenheit Pharmaceutical for no reason. The reason for this is to exclude Fahrenheit and exclude competitors for local American companies. Fahrenheit rejects such unfair treatment. With immediate effect, Fahrenheit Pharmaceuticals officially announced its withdrawal from the U.S. market. None of Fahrenheit's products will be sold in the U.S. market. The U.S. Bureau of Commerce must be punished for their actions. "Watson Pharmaceuticals completely withdrew from the United States in a very short period of time. The speed is astonishing.

Within a day, Americans were surprised to find that there was no trace of Fahrenheit products on the market. Fahrenheit's withdrawal was very complete. The Commerce Bureau's antitrust investigation has been unable to proceed. This is because Fahrenheit does not have any business in the United States. Take a legally operating Chinese company to court. Naturally, it is impossible to get the cooperation of the Chinese authorities. Even Europeans, who are allies of the United States, cannot support such an American approach.

Patients in the U.S. are starting to find that when they get sick, if they don't have the money to receive BS Pharmaceutical's super antibodies, then they have to re-use those that are not very effective. The side effects are not small. This time. They began to miss Fahrenheit. But. They forgot about it, and in the beginning, they also wished that Fahrenheit Group would be completely replaced by Bess Pharmaceutical. Right now. They are finally starting to miss the Chinese pharmaceutical company.

Bess Pharma did not give them any hope, and a spokesperson for Bess Pharma said that due to the extremely complex production process of super antibodies, the production efficiency is extremely low, so that the production cost of super antibodies has been high. There is no room for price reduction. If patients cannot afford the cost of superantibodies, they use other types of drugs that are cheaper. At the same time, he expressed great regret for the behavior of the Fahrenheit Group in disregard for the feelings of American patients.

Even more severely, a new type of flu hit the megacity of New York, and countless people fell ill with the flu overnight. What's even more troublesome is that this new influenza virus is extremely resistant to the original antiviral drugs. The old drugs of the past simply could not always be active against the new influenza virus.

In addition to super antibodies, Bess Pharma has not developed other types of drugs. After all, before this, Bess Pharmaceutical was on the verge of bankruptcy, with elixirs and super antibodies, and other research had been completely stalled. After the development of elixir and super antibody, it seems that it is no longer necessary to develop other drugs.

But the rapid spread of a new type of influenza virus has put the United States in huge trouble. Traditional drugs have no effect, and Fahrenheit's special drugs that may have been excellent have all been removed from the shelves, and it is unknown where those drugs end up. Fahrenheit seems to have known that Americans were in such trouble, and they withdrew all their drugs.

Even if Americans are rich enough to bear the high price of Bess Pharmaceutical, they are willing to become the wronged boss and be vaccinated with Bess Pharmaceutical's super antibodies. Bess Pharmaceuticals is also unable to provide a sufficient number of specific drugs.

The new influenza virus is extremely infectious, pathogenic, and can cause extremely severe consequences. After three days, the problem became even more serious. A patient with poor constitution died of a novel influenza virus. If that's all there might be, it won't be a big deal. The problem is that, at the same time, the same new flu virus has been found in Canada, a neighbor of the United States, but Canada has confirmed that Fahrenheit's cold medicine is very effective even against this new flu virus.

This time, the Americans completely quit. The Fahrenheit Group was forced away by the Ministry of Commerce. Now that such a big thing has happened, naturally someone must come out and take responsibility. There are also Americans who point the finger at Bess Medicine. Some media reporters in the United States have discovered that Bess Pharmaceutical has some secret connections with certain officials of the Department of Commerce. The reputation of Bess Medicine, which had originally made Americans hopeful, suddenly fell to a low point. After all, Bess Medicine has harmed the interests of too many people.

The new flu virus is still spreading rapidly, and panicked Americans are beginning to flood Canada. Fortunately, Fahrenheit does not seem prepared to embarrass Americans. It is not as restricted as it was in the past. Restrict Americans from purchasing miracle drugs from Canada. Large quantities of Fahrenheit's miracle drugs were smuggled from Canada to the United States. But Canada's quota is limited. With such a large-scale outbreak of virus infection, the demand for drugs increased suddenly, and soon Fahrenheit pharmaceutical products in the Canadian market were quickly out of stock. Although Fahrenheit urgently dispensed some medicines, it still could not meet the sudden expansion of demand.

Canadians began to complain about the large number of Americans buying large quantities of miracle drugs in Canada. Canadian authorities had to introduce regulations restricting Americans from buying Fahrenheit's cold medicine in Canada. to ensure that the supply of medicines to their nationals is not affected.

The U.S. government has also launched consultations with the Chinese side, hoping to use political means to resolve the current problem. But this approach doesn't seem to be working. The Chinese, who have always been good at talking, seem to be less enthusiastic this time. If the Chinese shirk it, the kung fu of tai chi has always been very clever. And now it is the Americans who are in a hurry. Diplomats conveyed Fahrenheit's message that Fahrenheit had been treated unfairly in the United States and had caused huge losses. If Fahrenheit is required to return to the U.S. market, Fahrenheit's conditions must be met. The first is to ensure that Fahrenheit will not be treated unfairly in the future. Second. Compensate Fahrenheit for damages caused by injustices on the part of the United States. Third. The Commerce Bureau must publicly apologize to Fahrenheit for its actions.

Naturally, this condition is difficult for Americans to accept. But now that the shape is stronger than the human being, the new influenza virus has spread widely in the United States. Although Bess Pharmaceutical's super antibody is effective, Bess Pharma is reluctant to reduce its drug to the low price of Fahrenheit's special drug. Although criticized by American public opinion, Bess Pharmaceutical still goes its own way. And it is true that Bess Pharma is not able to provide such a large number of drugs. According to the U.S. Centers for Disease Control and Prevention. More than 100 million people have been infected by the novel influenza virus in the United States. And it's spreading fast. The death toll has already reached dozens. They don't have time to wait. Otherwise, the resulting turmoil. No one can afford it.

Soon, the U.S. Secretary of Commerce announced his resignation. The Department of Commerce issued a statement because of the misconduct of certain individuals. We apologize for the mistreatment of Fahrenheit. And is willing to bear the losses caused by this. U.S. President Hinton said that this was an extremely serious act of corruption that undermined the principle of fairness that the United States upholds. It's a pity. Hopefully, Fahrenheit will return to the United States. The United States will guarantee that the legitimate interests of the Fahrenheit Group are not violated.

Fahrenheit Group also closed the favor and announced its return to the U.S. market. The next day, across the United States, a large number of Fahrenheit drugs appeared on the counters of various pharmacies. But these drugs were quickly sold out. A crisis was quickly quelled by Fahrenheit's miracle drug.

After the super antibody of Bess Pharmaceutical was launched, it did not open the Chinese market. So far, there is still no trace of super antibodies in the Chinese market. The main reasons are that the supply of Bess Pharmaceutical is still extremely limited, and it does not plan to open up the Chinese market in a short period of time. The second reason is that the super antibody has not yet obtained the Chinese drug license. The China Food and Drug Administration does not agree with the safety of Bess Pharmaceutical. The Food and Drug Administration has adopted Fahrenheit's food and drug safety simulation system. Initial testing of food and drugs can be carried out quickly. And the super antibody is not detected by guò.

"How is that possible? How can our medicines have safety issues? This is certified by the guò FDA. Everyone knows that the FDA is the most stringent drug certification mechanism in the world. Cassidy, a technician at Bess Pharmaceutical, believes that Bess Pharma has been affected by Fahrenheit Pharmaceutical from the Chinese side.

The reply from the China Food and Drug Administration was very simple: "After testing, it was found that your company's products have safety risks. The audit is not clear. ”

Subsequently, ABC TV reporter Rodrigo conducted an interview with the China Food and Drug Administration. Liu Xisheng was interviewed.

"There is a problem with your institution's safety certification for our products, can you tell us what happened? As we all know, Super Antibodies have been approved by the FDA. That's the most stringent certification in the world. Rodrigo asked.

Liu Xisheng said with a smile: "I don't know how the FDA determines whether there are safety problems with super antibodies. However, during the testing process, the China Food and Drug Administration found that there are huge safety risks in the safety of super antibodies. We use the latest testing technology to ensure that there are no problems with our testing. ”

"But many people think that the main reason why super antibodies can't live safely and seriously is that you have been influenced by Fahrenheit. Fahrenheit is the largest pharmaceutical company in China, and the owner of Fahrenheit is extremely mysterious in China. His influence can be used in the Food and Drug Administration. Rodrigo said.

"I don't want to explain anything more, time will tell. Out of a sense of responsibility in the world, our company has communicated with the FDA about the possible safety of Bess Pharmaceutical, hoping that they can re-evaluate the safety of Bess Pharma from a scientific point of view. I can sue you. The results of our simulation system show that if there is a problem with the super antibody, it will cause very severe results. The China Food and Drug Administration is in charge, and our approach can stand the test of time. Liu Xisheng said.

Bess Pharma is extremely dissatisfied with the statement of the China Food and Drug Administration, believing that the China Food and Drug Administration is completely irresponsible, and intends to investigate the responsibility of the China Food and Drug Administration. However, the China Food and Drug Administration simply ignored Bess Pharmaceutical's statement.

"I feel strong indignation at this irresponsible behavior of the China Food and Drug Administration. In view of this situation, Bess Pharmaceutical will not consider exploring the Chinese market for the time being. The elixir will only be sold to people outside of China. to protest against such actions by the China Food and Drug Administration. A spokesperson for Bess Pharma said publicly at a press conference.

The China Food and Drug Administration did not respond to Bess Pharmaceutical's remarks, but warned the Chinese: "In view of the hidden dangers of the safety of super antibodies, and the safety certification of the old drug has not been approved by the Food and Drug Administration, it is not recommended that Chinese and Chinese people use super antibodies or old drugs." ”

Watson has been calm, and although the peaks and turns have turned, Fahrenheit has not only not suffered losses, but has made a lot of money. And its international influence has also increased a lot.

"Master, according to the simulation results of our simulation system, the first batch of users of Bess Medicine's elixir should have a strict problem in the near future." Wang Jia said.

"What's going to go wrong?" Watson asked back. (To be continued......)